Artelo Biosciences, Inc. (ARTL) vs NEXGEL, Inc. (NXGL)

A side-by-side comparison of Artelo Biosciences, Inc. and NEXGEL, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ARTL

Artelo Biosciences, Inc.

$1M

$3.56HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT

NXGL

NEXGEL, Inc.

$1M

$0.17HealthcareDelayed quote: Oct 6, 2026, 12:48 PM EDT

Total return — ARTL vs NXGL

growth of $100 · dividends reinvested · last 5y

ARTL -99.3% (-62.8%/yr)NXGL -95.2% (-45.5%/yr)NXGL compounded faster over this window

Log scale — wide-divergence pair

ARTL NXGL

ARTL vs NXGL: by the numbers

•NXGL is the larger company ($1M vs $1M market cap).
•Both run net losses; ARTL's is the smaller (0.00% vs -51.26% net margin).

Metrics side by side

Valuation

Metric	ARTL	NXGL
P/S ratio	N/A	0.12
P/B ratio	0.28	0.29

Profitability

Metric	ARTL	NXGL
Gross margin	0.00%	35.07%
Operating margin	0.00%	-29.35%
Net margin	0.00%	-51.26%
ROE	-253.57%	-124.97%
ROIC	-219.36%	-41.80%

Growth (annualized)

Metric	ARTL	NXGL
Revenue CAGR (5Y)	N/A	63.69%
Total return CAGR (5Y)	-64.27%	N/A

Go deeper

Full ARTL analysis Full NXGL analysis Interactive comparison tool

Dig into the metrics

Artelo Biosciences ROE NEXGEL ROE Artelo Biosciences operating margin NEXGEL operating margin Artelo Biosciences revenue growth NEXGEL revenue growth Artelo Biosciences free cash flow NEXGEL free cash flow

Artelo Biosciences & NEXGEL appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.